San Ramon, CA – According to filings with the U.S. Securities and Exchange Commission, Bioventrix is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Ken Miller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bioventrix
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter based approaches. BioVentrix offers benefits to all stakeholders in heart failure: Patient improved survival and QOL by treating the underlying cause of HF less invasively Payor reduced hospitalizations and avoidance of more expensive, highly invasive procedures like transplant and LVAD Provider become a pioneer in heart failure and offer unique solutions to your patients, in the growing and most expensive disease state in the world.

To learn more about Bioventrix, visit http://www.bioventrix.com/

Contact:
Ken Miller, President and Chief Executive Officer
925-830-1000
kmiller@bioventrix.com
https://www.linkedin.com/in/ken-miller-3b75198/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved